期刊文献+

PD相关基因LRRK2表达调控的初探 被引量:2

Expression and regulation research of PD-related gene LRRK2
下载PDF
导出
摘要 目的:以C57BL/6J(B6)和DBA/2(D2)小鼠为实验动物,初步探究帕金森病(PD)相关基因LRRK2的表达调控机制,构建LRRK2的表达调控网络。方法:数量性状基因座(eQTL)分析技术分析LRRK2基因在各品系小鼠中的表达情况,并进行遗传学相关分析和区间连锁分析;半定量PCR技术和Real-time PCR检测LRRK2基因在PD模型组和对照组小鼠中的表达量。结果:与NS对照组相比,B6、D2小鼠PD模型组的中脑及前脑中LRRK2基因的mRNA表达水平都发生了非常显著的变化(P<0.01)。eQTL分析发现在Affymetrix MOE430芯片中,LRRK2基因共有2个探针位置用于分析其在前脑、中脑的mRNA表达水平。选取探针位置1431394_a_at_A进行检测,结果显示,LRRK2基因在亲本B6、D2及41个BXD RI小鼠前脑、中脑的表达在各品系间的表达量多少不一。遗传学相关分析结果揭示,LRRK2基因与100个基因高度相关,初步构建LRRK2基因的调控网络,该网络包括了Kif21a等21个与LRRK2基因高度相关的基因。区间连锁分析检测引起探针位置1431394_a_at_A表达水平差异的染色体区域,结果显示在15号染色体和4号染色体各存在一个LRS≥20的QTL峰。结论:LRRK2基因既存在顺式调控机制又存在反式调控机制。 Objective:To study initially the expression regulation mechanism and regulatory networks for LRRK2 gene related PD using C57BL/6J(B6) and DBA/2(D2) mouse as experimental animals.Methods:Using eQTL analysis technology,Genetics-related analysis as well as interval linkage analysis to detect the LRRK2 gene expression value in mouse;and semi-quantitative PCR was used to detect the expression of LRRK2 gene in PD model group and control group.Results:Compared with the NS control group,the expression of LRRK2 gene mRNA have undergone significant changes in the midbrain and forebrain of PD model group(P0.01).The eQTL analysis for the LRRK2 gene revealed that there were the two Probe Sets in the Affymetrix MOE430 chip,which could be used to analyze the mRNA expression levels.We select Probe Set 1431394_a_at_A for subsequent analysis due to its high expression and because it is located in the encoding area.The eQTL detection revealed that the LRRK2 expression levels were different between the two different strains.Genetics-related analysis proved that there were one hundred genes highly related to LRRK2 gene.We initially constructed the LRRK2 gene regulatory network,which included twenty-one genes highly related with LRRK2 such as Kif21a.The interval linkage analysis showned that the chromosomal regions caused the differences in expression levels of Probe Set 1431394_a_at_A,resulted in two peaks with LRS(Likelihood ratio statistics,the level of chain groups significant threshold) ≥20 at chromosome 15 and chromosome4.Conclusion:LRRK2 gene expression regulation exits both cis-regulatory and trans-regulatory mechanism.
出处 《南通大学学报(医学版)》 2011年第6期409-413,417,共6页 Journal of Nantong University(Medical sciences)
基金 国家自然科学基金资助项目(30770666) 江苏省大学生实践创新训练计划项目
关键词 帕金森病 LRRK2基因 调控网络 数量性状基因座 小鼠 Parkinson's disease LRRK2 gene regulatory networks quantitative trait loci mouse
  • 相关文献

参考文献4

二级参考文献74

  • 1MacLeod D, Dowman J, Hammond R, et al. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron, 2006, 52 : 587-593.
  • 2Plowey ED, Cherra SJ 3rd, Liu YJ, et al. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SYSY cells. J Neurocbem, 2008,105 : 1048-1056.
  • 3Hatano T, Kubo S, Imai S, et al. Leucine-rich repeat kinase 2 associates with lipid rafts. Hum Mol Genet, 2007,16:678-690.
  • 4Shin N, Jeong H, Kwon J, et al. LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res , 2008,314:2055-2065.
  • 5Greggio E, lewis PA, van der Brag MP, et al. Mutations in LRRK2/ dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J Neurochem, 2007,102: 93- 102.
  • 6West AB, Moore DJ, Choi C, et al. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum Mol Genet, 2007,16:223-232.
  • 7Guo L, Gandhi PN, Wang W, et al. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res, 2007,313 : 3658-3670.
  • 8Greggio E, Zambrano I, Kaganovich A, et al. The Parkinson disease-associated leucine-rieh repeat kinase 2 (LRRK2) is a dimer that undergoes intramoleeular autophosphorylation. J Biol Chem, 2008, 283 : 16906- 16914.
  • 9Greggio E, Jain S, Kingsbury A, et al. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis, 2006, 23 : 329- 341.
  • 10Skipper L, Shen H, Chua E, et al. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology, 2005, 65 : 1319- 1321.

共引文献9

同被引文献16

  • 1DriverJA, Logroscino G, GazianoJM, et al. Incidence and remaining lifetime risk of Parkinson disease in advanced age [J]. Neurology, 2009, 72(5) :432438.
  • 2Kumari U, Tan EK. LRRK2 in Parkinson's disease: genetic and clinical studies from patients [J]. FEBSJ, 2009, 276 ( 22 ) : 6455-6563.
  • 3Saiki S, Sato S, Hattori N. Molecular pathogenesis of Parkinson's disease: update [J].J N eurol N eurosurg Psychiatry, 2012, 83 (4) :430436.
  • 4Bardien S, Lesage S, Brice A, et al. Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease [J]. Parkinsonism Relat Disord, 2011 , 17 (7) : 50 1-508.
  • 5Greggio E, Bisaglia M, Civiero L, et al, Leucine-rich repeat kinase 2 and alpha-synuclein , intersecting pathways in the pathogenesis of Parkinson's disease? [J]. Mol Neurodegener, 2011, 6(1) :6.
  • 6Pennisi E. A closer look at SNPs suggests difficulties [J]. Science. 1998. 281 (5384) : 1787-1789.
  • 7Syvanen AC. Accessing genetic variation: genotyping single nucleotide polymorphisms [Jl. Nat Rev Genet. 2001. 2 (12) : 930-942.
  • 8Cottgens B. Barton L M. GilbertJ G. et al. Analysis of vertebrate SCL loci identifies conserved enhancers [J]. Nat Biotechnol , 2000. 18(2): 181-186.
  • 9Tao H. Cox DR. Frazer K A. Allele-specific KRTl expression is a complex trait [Jl. PLoS Genet. 2006. 2 ( 6) : 91-93.
  • 10Mata IF. Wedemeyer WJ, Farrer MJ. et al. LRRK2 in Parkinson' s disease: protein domains and functional insights [J]. Trends Neurosci .2006 .29( 5) : 286-293.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部